Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5)

Dominik H Pesta, Rachel J Perry, Fitsum Guebre-Egziabher, Dongyan Zhang, Michael Jurczak, Antje Fischer-Rosinsky, Martin A Daniels, Diana M Willmes, Sanjay Bhanot, Stefan R Bornstein, Felix Knauf, Varman T Samuel, Gerald I Shulman, Andreas L Birkenfeld

Diabetes

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich-Heine University Düsseldorf, German Center for Diabetes Research, Partner Düsseldorf, Düsseldorf, Germany.
Yale University
Charité University of Medicine Berlin
Section of Metabolic Vascular Medicine, Medical Clinic III, and Paul Langerhans Institute Dresden (PLID), Dresden University of Technology, Dresden, Germany.
Paul Langerhans Institute Dresden (PLID), A Member of the German Center for Diabetes Research (DZD e.V.), Dresden, Germany.
Isis Pharmaceuticals, Carlsbad, CA, USA.
Section of Diabetes and Nutritional Sciences, Rayne Institute, Denmark Hill Campus, King's College London, United Kingdom.
Department of Child and Adolescent Mental Health, University Clinic Erlangen, Erlangen, Germany.
Veterans Affairs Medical Center, West Haven, CT, USA.

Research output: Contribution to journal › Article › peer-review

35 Citations (Scopus)

Prevention of diet-induced hepatic steatosis and hepatic insulin resistance by second generation antisense oligonucleotides targeted to the longevity gene mIndy (Slc13a5)

Fingerprint

Biochemistry, Genetics and Molecular Biology